UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms

Scientific reports, 2019-02, Vol.9 (1), p.2176-2176, Article 2176

2019

Volltextzugriff (PDF)

Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment

Cancers, 2019-08, Vol.11 (9), p.1279

2019

Volltextzugriff (PDF)

Unusual Presentations for EBV and HHV8 Co-Infections: A Case Report and Review of Literature

Journal of Clinical Case Studies Reviews & Reports, 2023-09, Vol.5 (9), p.1-6

Cingarlini, Sara

2023

Volltextzugriff (PDF)

Derangement of immune responses by myeloid suppressor cells

Cancer Immunology, Immunotherapy, 2004-02, Vol.53 (2), p.64-72

2004

Volltextzugriff (PDF)

Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers

Heliyon, 2023-10, Vol.9 (10), p.e20770-e20770, Article e20770

2023

Volltextzugriff (PDF)

Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake

Cancers, 2020-06, Vol.12 (6), p.1486

2020

Volltextzugriff (PDF)

Imaging presentation of pancreatic neuroendocrine neoplasms

Insights into imaging, 2018-12, Vol.9 (6), p.943-953

2018

Volltextzugriff (PDF)

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

Cancers, 2021-08, Vol.13 (16), p.4152

2021

Volltextzugriff (PDF)

Double tracer PET/CT: what is it and what does it mean?

Journal of cancer metastasis and treatment, 2016-08, Vol.2 (8), p.321

2016

Volltextzugriff (PDF)

Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors

Surgery, 2020-11, Vol.168 (5), p.816-824

2020

Volltextzugriff (PDF)

Precision medicine applied to rare malignancies: A single-center experience at University Hospital of Verona

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16296-e16296

2023

Volltextzugriff (PDF)

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Gastroenterology (New York, N.Y. 1943), 2018-08, Vol.155 (2), p.479-489.e7

2018

Volltextzugriff (PDF)

Clinical and pathological prognostic factors in Merkel cell carcinoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21574-e21574

2022

Volltextzugriff (PDF)

Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups

Pathology, research and practice, 2023-08, Vol.248, p.154674-154674, Article 154674

2023

Volltextzugriff (PDF)

From seed to harvest: 18-month experience of molecular tumor board (MTB)-based precision oncology practice at the Verona University Hospital

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15065-e15065

2023

Volltextzugriff (PDF)

Adult-Onset Metastatic Pancreatic Ganglioneuroblastoma with ALK Gain-of-Function Mutation P.R1275Q Treated with Lorlatinib

Journal of Clinical Studies & Medical Case Reports, 2023-02, p.1-4

Sara, Cingarlini

2023

Volltextzugriff (PDF)

The development of PARP as a successful target for cancer therapy

Expert review of anticancer therapy, 2018-02, Vol.18 (2), p.161-175

2018

Volltextzugriff (PDF)

Abstract 3814: Molecular background conditioning by temozolomide in neuroendocrine tumors

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.3814-3814

2024

Volltextzugriff (PDF)

Abstract B096: A comparative assessment of selinexor with trabectedin or lurbinectedin in patient-derived xenografts (PDX) of dedifferentiated liposarcoma (DDLPS) highlights the effectiveness of their sequential or concomitant combination

Molecular cancer therapeutics, 2023-12, Vol.22 (12_Supplement), p.B096-B096

2023

Volltextzugriff (PDF)

The evolution of surgical strategies for pancreatic neuroendocrine tumors

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2017-09, Vol.17 (4), p.S19-S19

2017

Volltextzugriff (PDF)

IFN-γ-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer

Vaccine, 2010-04, Vol.28 (20), p.3548-3557

2010

Volltextzugriff (PDF)

Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical Series

Neuroendocrinology, 2018-04, Vol.106 (3), p.234-241

2018

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms

Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors

Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment

Unusual Presentations for EBV and HHV8 Co-Infections: A Case Report and Review of Literature

Derangement of immune responses by myeloid suppressor cells

Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers

Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake

Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143)

Imaging presentation of pancreatic neuroendocrine neoplasms

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?

Double tracer PET/CT: what is it and what does it mean?

Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors

Precision medicine applied to rare malignancies: A single-center experience at University Hospital of Verona

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Clinical and pathological prognostic factors in Merkel cell carcinoma

Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups

From seed to harvest: 18-month experience of molecular tumor board (MTB)-based precision oncology practice at the Verona University Hospital

Adult-Onset Metastatic Pancreatic Ganglioneuroblastoma with ALK Gain-of-Function Mutation P.R1275Q Treated with Lorlatinib

The development of PARP as a successful target for cancer therapy

Abstract 3814: Molecular background conditioning by temozolomide in neuroendocrine tumors

Abstract B096: A comparative assessment of selinexor with trabectedin or lurbinectedin in patient-derived xenografts (PDX) of dedifferentiated liposarcoma (DDLPS) highlights the effectiveness of their sequential or concomitant combination

Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres)

The evolution of surgical strategies for pancreatic neuroendocrine tumors

IFN-γ-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer

Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical Series

Aktive Filter

Suchergebnisse filtern